About ML Bio Solutions
ML Bio Solutions is a company based in Charlotte (United States) founded in 2017. It operates as a B2B. ML Bio Solutions offers products and services including BBP-418, Attruby, and Nulibry. ML Bio Solutions operates in a competitive market with competitors including Juvena Therapeutics, Expansion Therapeutics, Vita Therapeutics, Amplicore and Sarcomatrix, among others.
- Headquarter Charlotte, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bridgebio Pharma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ML Bio Solutions
ML Bio Solutions offers a comprehensive portfolio of products and services, including BBP-418, Attruby, and Nulibry. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral treatment targeting FKRP gene variants for LGMD2I/R9.
Product for genetic disorders, focusing on muscle stabilization.
Addresses rare diseases through enzyme-related interventions.
Funding Insights of ML Bio Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ML Bio Solutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ML Bio Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ml Bio Solutions Comparisons
Competitors of ML Bio Solutions
ML Bio Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Juvena Therapeutics, Expansion Therapeutics, Vita Therapeutics, Amplicore and Sarcomatrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based therapies for sarcopenia and muscle regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Software for RNA-based drug development is provided by the company.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for muscular dystrophies are developed using iPSC technology.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for musculoskeletal diseases are provided.
|
|
| domain | founded_year | HQ Location |
Biotech firm developing drugs for muscular dystrophies and related muscle conditions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ML Bio Solutions
When was ML Bio Solutions founded?
ML Bio Solutions was founded in 2017.
Where is ML Bio Solutions located?
ML Bio Solutions is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.
What does ML Bio Solutions do?
BridgeBio Pharma focuses on researching and developing treatments for rare genetic diseases, including LGMD2IR9 caused by FKRP gene variants. They use advanced glycosylation processes to stabilize muscle cells and prevent degeneration. The company partners with affiliates like ML Bio Solutions for clinical trials and licensing opportunities. Based in Palo Alto, USA, they aim to address unmet needs through innovative therapies, conducting studies and publishing findings to improve patient outcomes.
Who are the top competitors of ML Bio Solutions?
ML Bio Solutions's top competitors include Juvena Therapeutics, Vita Therapeutics and Expansion Therapeutics.
What products or services does ML Bio Solutions offer?
ML Bio Solutions offers BBP-418, Attruby, and Nulibry.